₹14.75 Crores | Listing at BSE | Mon, Apr 18, 2022 - Wed, Apr 27, 2022
Makers Laboratories Limited Rights Issue comprises 0.0983 Cr equity shares aggregating to ₹14.75 Cr, offered at an issue price of ₹150 per share with a face value of ₹10 per share.
The record date for determining eligible shareholders is Apr 1, 2022.
As per the terms of payment, ₹150 per share payable in full at the time of application.
The Rights Entitlements are expected to be credited to eligible demat accounts on Apr 11, 2022.
The Rights Issue opens on Apr 18, 2022, and closes on Apr 27, 2022, with renunciation of Rights Entitlements permitted up to Apr 22, 2022.
The deemed date of allotment is May 6, 2022, following which the equity shares are expected to be credited to demat accounts on May 9, 2022 and listed on the BSE on May 11, 2022.
Arihant Capital Markets Ltd. is the Lead Manager to the issue and MUFG Intime India Pvt.Ltd. is the Registrar to the Issue.
Investors are advised to refer to the Makers Laboratories Limited Letter of Offer for detailed information, including risk factors, issue terms, and procedural details.
Record Date
Fri, Apr 1, 2022
Entitlement Ratio
:
Open Date
Mon, Apr 18, 2022
Close Date
Wed, Apr 27, 2022
| Particulars | For the year/period ended (Rs in Lakhs) | ||||
|---|---|---|---|---|---|
| 31-Mar-21 | 31-Mar-20 | ||||
| Total Assets | 7,911.59 | 7,387.49 | |||
| Total Revenue | 4,482.54 | 5,162.21 | |||
| Profit After Tax | -161.66 | -12.38 | |||
Incorporated in 1984, Makers Laboratories Limited is a Pharmaceutical Company that engages in the business of marketing Branded Generic Pharmaceutical Formulations such as Duramol (Paracetamol), Artemak-AB (α-β Arteether), Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffin (Anti cough Range) and Exylin (Amoxycillin range).
The company has a product range of 170 products in therapy segments such as Anti Malarials, Analgesics, Anti Pyretics, Anti-Allergy, Nutritional Supplements, Dermatology, Ophthalmic, Anti Diabetic, Anti-Hypertensives etc. Makers Laboratories has warehouses in Ahmedabad, Ambala, and Mumbai, which cater to Distributors across India.
The company operates on a PAN India basis with a strong distribution network of 20 Consignment Agents and 15 Super Stockiest, catering to more than 1500 Stockiest, 1,00,000 Doctors and 2,00,000 Retailers.
The Company intends to utilize the Proceeds from the Issue towards funding of the following objects:
[Dilip Davda] The company has suffered a setback and skipped dividends since FY19. For the 3Qs of FY22, it has posted improved performance. Based on its financial data, the RI is fully priced. Investors may consider an investment with a long term perspective only. Read detail review...
Makers Laboratories Limited
54-D,
Kandivli Industrial Estate,
Kandivli (W), Mumbai, 400067
Mumbai, Maharashtra, 400067
The Makers Laboratories Rights Issue 2022 opens on Mon, Apr 18, 2022, and closes on Wed, Apr 27, 2022.
Makers Laboratories Rights Issue 2022 Schedule
| Last Date for credit of Rights Entitlements | Mon, Apr 11, 2022 |
| Last Date for renunciation of Rights Entitlements | Fri, Apr 22, 2022 |
| Issue Opening Date | Mon, Apr 18, 2022 |
| Issue Closing Date | Wed, Apr 27, 2022 |
| Date of Allotment (on or about) | Fri, May 6, 2022 |
| Date of Credit (on or about) | Mon, May 9, 2022 |
| Date of Listing (on or about) | Wed, May 11, 2022 |
You can apply for Makers Laboratories Rights Issue 2022 in two ways:
Steps to apply for Makers Laboratories Rights Issue 2022 using Net Banking (ASBA)
Steps to apply for Makers Laboratories Rights Issue 2022 using Registrar's website (R-WAP)
